Tess Burleson serves as Executive at Salarius Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Tess Burleson has executed 3 insider transactions totaling $10.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 3, 2023 involved receiving (via award) 1,440 shares valued at $0.
Tess Burleson currently holds 2,722 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tess Burleson has been a net buyer of SLRX stock. They have purchased $10.0K and sold $0 worth of shares.
Tess Burleson's most recent insider trade was on Jan 3, 2023, when they sold 1,440 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.18 |
| Discretionary |
| Feb 11, 2020 | SLRX | $5.0K | Purchase | 4,350 | $1.15 | Discretionary |